Key Takeaways
- • Ares Management expects Q4 2025 earnings of $1.70 per share on $1.52 billion in revenue, representing 43% and 42% sequential growth respectively, signaling strong momentum despite recent stock volatility.
- • Wall Street consensus rates Ares a Buy with a mean price target of $194.63, implying 48% upside from the $131.60 current price, though the stock has declined 33% from its 52-week high of $195.26.
- • Ares raised $7.1 billion for its debut private credit secondaries strategy in January, demonstrating sustained investor appetite for alternative strategies amid a competitive fundraising environment.
- • Assets under management stand at $595 billion as of September, with fourth-quarter inflows and 2026 pipeline guidance expected to be critical metrics for investor scrutiny.
- • Private credit faces its first meaningful test after a decade of benign credit conditions, though alternative asset managers are positioned to benefit from anticipated lower interest rates, M&A acceleration, and regulatory easing in 2026.
Summary
Ares Management is poised to report fourth-quarter 2025 earnings Thursday before market open at a critical juncture for the alternative asset manager, as the firm navigates exceptional fundraising momentum alongside heightened industry scrutiny of private credit. Consensus analyst expectations call for earnings of $1.70 per share on revenue of $1.52 billion for the quarter ended December 31, representing substantial sequential gains of 43% and 42%, respectively, compared to the prior quarter.
The earnings report arrives amid a broader tailwind for alternative asset managers, who are expected to benefit from anticipated lower interest rates, increased M&A activity, and potential regulatory reform in 2026. However, the private credit segment—a major driver of industry growth—faces its first genuine credit stress test following a decade of expansion supported by exceptionally benign credit conditions. This inflection point will influence investor confidence in sustainability of fundraising and fee growth across the sector.
Market sentiment on Ares remains constructive despite recent volatility. Seventeen analysts maintain a consensus Buy rating with a mean price target of $194.63, implying approximately 48% upside from the current stock price of $131.60. The stock has declined roughly 33% from its 52-week high of $195.26; however, several analysts have raised price targets recently, including Oppenheimer's January increase to $224 from $190, signaling sustained conviction in the firm's strategic positioning. Revenue estimates have risen 3.94% over the past two months, while EPS estimates have declined 1.28% over the same period, suggesting investors are prioritizing asset-gathering and top-line expansion over near-term profitability.
Fundraising momentum will be the primary focus for market participants. Ares collected $7.1 billion for its inaugural private credit secondaries strategy in January, underscoring robust investor appetite for alternative strategies despite broader market concerns. With assets under management at $595 billion as of September, management commentary on fourth-quarter inflows and the 2026 investment pipeline will receive intensive scrutiny from institutional investors and analysts evaluating the firm's competitive positioning in the increasingly crowded alternative asset management landscape.
The earnings report arrives amid a broader tailwind for alternative asset managers, who are expected to benefit from anticipated lower interest rates, increased M&A activity, and potential regulatory reform in 2026. However, the private credit segment—a major driver of industry growth—faces its first genuine credit stress test following a decade of expansion supported by exceptionally benign credit conditions. This inflection point will influence investor confidence in sustainability of fundraising and fee growth across the sector.
Market sentiment on Ares remains constructive despite recent volatility. Seventeen analysts maintain a consensus Buy rating with a mean price target of $194.63, implying approximately 48% upside from the current stock price of $131.60. The stock has declined roughly 33% from its 52-week high of $195.26; however, several analysts have raised price targets recently, including Oppenheimer's January increase to $224 from $190, signaling sustained conviction in the firm's strategic positioning. Revenue estimates have risen 3.94% over the past two months, while EPS estimates have declined 1.28% over the same period, suggesting investors are prioritizing asset-gathering and top-line expansion over near-term profitability.
Fundraising momentum will be the primary focus for market participants. Ares collected $7.1 billion for its inaugural private credit secondaries strategy in January, underscoring robust investor appetite for alternative strategies despite broader market concerns. With assets under management at $595 billion as of September, management commentary on fourth-quarter inflows and the 2026 investment pipeline will receive intensive scrutiny from institutional investors and analysts evaluating the firm's competitive positioning in the increasingly crowded alternative asset management landscape.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.